化合物USP7-IN-8 T9217
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
5 mg | 2009273-60-1 | ¥1,630.00 | 询底价 |
25 mg | 2009273-60-1 | ¥4,430.00 | 询底价 |
10 mg | 2009273-60-1 | ¥2,630.00 | 询底价 |
50 mg | 2009273-60-1 | ¥6,320.00 | 询底价 |
1 mg | 2009273-60-1 | ¥685.00 | 询底价 |
1 mL | 2009273-60-1 | ¥1,820.00 | 询底价 |
500 mg | 2009273-60-1 | ¥17,300.00 | 询底价 |
100 mg | 2009273-60-1 | ¥8,660.00 | 询底价 |
Product Introduction
Bioactivity
英文名: USP7-IN-8
描述: USP7-IN-8 (GNE-6776) 是一种选择性泛素特异性蛋白酶 7 (USP7) 抑制剂,IC50 为 1.4 μM。它具有抗癌作用。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 80 mg/mL(230.08 mM)
关键字: inhibit | USP7 | USP7-IN-8 | Inhibitor | USP-7-IN-8 | Deubiquitinase | GNE6776 | GNE 6776 | DUBs | USP7IN8 | anticancer | USP7 IN 8
相关产品: GSK2643943A | TCID | USP30 inhibitor 11 | USP7/USP47 inhibitor | Degrasyn | USP8-IN-2 | VLX1570 | C527 | FT827 | Vialinin A
相关库: HIF-1 Signaling Pathway Compound Library | Cell Cycle Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Ubiquitination Compound Library | Inhibitor Library | Anti-Cancer Active Compound Library | DNA Damage & Repair Compound Library | NO PAINS Compound Library | Bioactive Compound Library
化合物USP7-IN-8 T9217信息由TargetMol中国为您提供,如您想了解更多关于化合物USP7-IN-8 T9217报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途